{
  "cik": 1933414,
  "cik_padded": "0001933414",
  "entityName": "Mineralys Therapeutics, Inc.",
  "fiscal_years": [
    {
      "accn": "0001933414-26-000056",
      "filed": "2026-03-12",
      "fiscal_year": 2025,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD"
      },
      "fundamentals": {
        "capex": 15000.0,
        "cash": 172921000.0,
        "eps_diluted": -2.29,
        "free_cash_flow": -142431000.0,
        "net_income": -154651000.0,
        "operating_cash_flow": -142416000.0,
        "operating_income": -170604000.0,
        "stockholders_equity": 646693000.0,
        "total_assets": 661806000.0
      },
      "period_end": "2025-12-31",
      "ratio_units": {
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "roa_avg2y": -0.3564582135255022,
        "roa_period_end": -0.233680262796046,
        "roe_avg2y": -0.36911748911032877,
        "roe_period_end": -0.23914129269993645
      }
    },
    {
      "accn": "0001933414-26-000056",
      "filed": "2026-03-12",
      "fiscal_year": 2024,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD"
      },
      "fundamentals": {
        "capex": 96000.0,
        "cash": 114091000.0,
        "eps_diluted": -3.66,
        "free_cash_flow": -166410000.0,
        "net_income": -177810000.0,
        "operating_cash_flow": -166314000.0,
        "operating_income": -192403000.0,
        "stockholders_equity": 191257000.0,
        "total_assets": 205903000.0
      },
      "period_end": "2024-12-31",
      "ratio_units": {
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "roa_avg2y": -0.7772452184403953,
        "roa_period_end": -0.8635619684997304,
        "roe_avg2y": -0.822412010795285,
        "roe_period_end": -0.9296914622732763
      }
    },
    {
      "accn": "0001933414-26-000056",
      "filed": "2026-03-12",
      "fiscal_year": 2023,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD"
      },
      "fundamentals": {
        "capex": 0.0,
        "cash": 49304000.0,
        "eps_diluted": -1.99,
        "free_cash_flow": -81173000.0,
        "net_income": -71898000.0,
        "operating_cash_flow": -81173000.0,
        "operating_income": -84657000.0,
        "stockholders_equity": 241154000.0,
        "total_assets": 251636000.0
      },
      "period_end": "2023-12-31",
      "ratio_units": {
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "roa_avg2y": -0.3928015340992903,
        "roa_period_end": -0.2857222337026499,
        "roe_avg2y": -0.7612886147655982,
        "roe_period_end": -0.29814143659238496
      }
    },
    {
      "accn": "0001933414-25-000009",
      "filed": "2025-02-12",
      "fiscal_year": 2022,
      "form": "10-K",
      "fundamental_units": {
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD"
      },
      "fundamentals": {
        "cash": 87701000.0,
        "eps_diluted": -5.77,
        "net_income": -29799000.0,
        "operating_cash_flow": -29221000.0,
        "operating_income": -31479000.0,
        "stockholders_equity": -52269000.0,
        "total_assets": 114442000.0
      },
      "period_end": "2022-12-31",
      "ratio_units": {
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio"
      },
      "ratios": {
        "roa_period_end": -0.26038517327554567,
        "roe_avg2y": 0.7925898342952895
      }
    },
    {
      "accn": "0001628280-24-012358",
      "filed": "2024-03-21",
      "fiscal_year": 2021,
      "form": "10-K",
      "fundamental_units": {
        "stockholders_equity": "USD"
      },
      "fundamentals": {
        "stockholders_equity": -22925000.0
      },
      "period_end": "2021-12-31",
      "ratios": {}
    }
  ],
  "latest_filing": {
    "accn": "0001933414-26-000056",
    "filed": "2026-03-12",
    "form": "10-K"
  },
  "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.",
  "schema_version": "1",
  "sic": "2834",
  "sic_description": "Pharmaceutical Preparations",
  "source_urls": {
    "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001933414.json",
    "sec_submissions": "https://data.sec.gov/submissions/CIK0001933414.json"
  },
  "ticker": "MLYS"
}